Join to View Full Profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2000
Dr. Bosl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1977 - 1979
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1973 - 1975
Creighton University School of MedicineClass of 1973
Certifications & Licensure
NY State Medical License 1974 - 2026
MN State Medical License 1977 - 1979
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
- CMS Meaningful Use Stage Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- America's Top Doctors Castle Connolly, 2002-2014
Publications & Presentations
PubMed
- Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.Prashasti Agrawal, Fady Baky, Judy Sarungbam, Joel Sheinfeld, Victor E Reuter
Annals of Surgical Oncology. 2025-12-01 - ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma.Prashasti Agrawal, Fady Baky, Judy Sarungbam, Joel Sheinfeld, Victor E Reuter
Annals of Surgical Oncology. 2025-09-15 - 7 citationsPaclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.Jack P Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld
Journal of Clinical Oncology. 2024-09-10
Press Mentions
Examining the Role of Docetaxel with Radiation Therapy and ADT in Non-Metastatic Prostate Cancer - Anthony D'Amico & Philip KantoffJune 7th, 2021
How Often to Follow up? Study Shows Two CT Scans as Good as Five for Low-Risk Testicular CancerJune 25th, 2007
Grant Support
- Development Of An Aging And Cancer Program At MskccNational Cancer Institute2003–2007
- Cancer Chemotherapy Training ProgramNational Cancer Institute1996–2005
- Cancer Chemotherapy Program ProjectNational Cancer Institute2001–2004
- Mechanism Of Action Of Folate AntagonistsNational Cancer Institute2002
- Solid TumorNational Cancer Institute2001–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
